Antimicrobial resistance (AMR) is emerging as one of most serious public health threats of our times. Here I will be presenting our recent efforts on applying systems-based approaches to different angles of the problem – from identifying the mode-of-action of new compounds to understanding new AMR risks, and from exploring the potential of drug combinations for new therapies to their use to reduce the collateral damage of antibiotics to the gut microbiota.